This HTML5 document contains 135 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n10http://dx.doi.org/10.14348/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q40160001
rdf:type
wikibase:Item
schema:description
videnskabelig artikel scientific article published on 14 June 2017 article scientific 2017年論文 2017年论文 επιστημονικό άρθρο artigo científico мақолаи илмӣ vědecký článek article científic научни чланак 2017年の論文 2017年论文 article scientifique scientific article published on 14 June 2017 bilimsel makale tudományos cikk 2017年論文 vitenskapelig artikkel artikull shkencor 2017年论文 artykuł naukowy บทความทางวิทยาศาสตร์ articol științific bài báo khoa học научная статья مقالة علمية نشرت في 14 يونيو 2017 naučni članak wetenschappelijk artikel artigo científico 2017年论文 artigo científico vetenskaplig artikel tieteellinen artikkeli 2017 nî lūn-bûn 2017年论文 artikel ilmiah teaduslik artikkel наукова стаття, опублікована в червні 2017 2017年論文 научна статия 2017년 논문 wissenschaftlicher Artikel სამეცნიერო სტატია vedecký článok 2017年論文 scientific article published on 14 June 2017 articolo scientifico scienca artikolo ১৪ জুন ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículu científicu espublizáu en 2017 2017年論文 artikulong pang-agham artículo científico publicado en 2017 2017年论文 מאמר מדעי научни чланак vitskapeleg artikkel
p:P577
wds:Q40160001-BBDD24E2-FBFF-416E-A908-2AD84B6CFAD2
wdt:P577
2017-06-14T00:00:00Z
p:P2860
wds:Q40160001-0388B26D-D229-4985-BA29-BDEC5B9CCF09 wds:Q40160001-28FF1CE2-26D7-4204-B414-78FFB062B6F4 wds:Q40160001-368495FD-ADDA-4475-8EDA-49D6865639B9 wds:Q40160001-3E696B64-BEDA-4613-80FA-7E860014DC08 wds:Q40160001-813ED11B-4A92-4198-8156-44129D7035D2 wds:Q40160001-858C5A92-9BAB-4A0B-B99B-872AEFF779E4 wds:Q40160001-8B1FCBE0-FDE1-4401-809C-57F40AF9BEAA wds:Q40160001-9430F4A7-1B07-46BE-BB6B-B29DACBF7396 wds:Q40160001-A8FA9FB7-4D9A-42E0-BCA6-BED146825241 wds:Q40160001-AB7AE0BE-329A-4838-815D-6AC809BE24E2 wds:Q40160001-AD2DA4E0-2B08-46D3-A1EF-E99DC0CE9B1B wds:Q40160001-D0889876-011F-4088-B51D-6554065E7942 wds:Q40160001-D3868F99-4463-4130-9D5E-04462947FBE2 wds:Q40160001-DF0F5A91-CD68-4E86-B004-14567511C2FD
wdt:P2860
wd:Q50862497 wd:Q44066989 wd:Q43258398 wd:Q37032966 wd:Q42233178 wd:Q40004980 wd:Q44468791 wd:Q36014403 wd:Q41157144 wd:Q40919115 wd:Q85356563 wd:Q40956888 wd:Q85323799 wd:Q45740965
p:P2093
wds:Q40160001-B377F25F-6B42-4AFE-91B4-349884D6FEB5 wds:Q40160001-FD977C93-7B71-48F9-B1B1-0EEE29A1A2BD wds:Q40160001-F388BE9D-9808-4445-82D8-0D86D82F212F wds:Q40160001-FA796936-92FA-4667-AFAE-F428B7DEFDE5 wds:Q40160001-663E3220-E14A-4323-B613-8F3E7D210534 wds:Q40160001-72CFDC5C-D471-400A-ABE6-9655C9DA10F6 wds:Q40160001-53BABD95-C602-47C2-AF7F-C601EB83F6CF wds:Q40160001-A9D7F07F-685E-4474-9DF4-3354386F989C wds:Q40160001-0C54E03E-49A9-4070-81A2-1B7F4E20E4DC
wdt:P2093
Wengang Song Mimi Sun Lei Jin Kai Zhao Wei Zhang Qinghua Shang Tao Yang Gang Chen Yong An
rdfs:label
IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir
skos:prefLabel
IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir
schema:name
IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir
p:P1476
wds:Q40160001-B179BFE7-7B63-4732-9DDF-807C4D96C46E
wdt:P1476
IP-10 Expression in Patients with Chronic HBV Infection and Its Ability to Predict the Decrease in HBsAg Levels after Treatment with Entecavir
p:P304
wds:Q40160001-3128CD4F-0FE9-42F8-AD4C-AAB12FAED4EC
wdt:P304
418-425
p:P31
wds:Q40160001-5E44AF6A-AB57-41D4-AD18-BF5157810BD7
wdt:P31
wd:Q13442814
p:P698
wds:Q40160001-77564BB4-6BD3-40BF-968D-5C068E9D379B
wdtn:P698
n11:28614914
wdt:P698
28614914
p:P1433
wds:Q40160001-B20C0642-65E7-48AD-B26C-B2E2CBAECE35
wdt:P1433
wd:Q12623193
p:P433
wds:Q40160001-BA433C2F-E41C-49D9-9B69-F26D4E63A4DE
p:P478
wds:Q40160001-ABD1AEEC-88A2-4E05-BAE0-ED1501DA1F4F
wdt:P433
6
wdt:P478
40
p:P356
wds:Q40160001-D54795BE-BBEF-4E19-A44F-ED8E06C15067
wdtn:P356
n10:MOLCELLS.2017.0051
wdt:P356
10.14348/MOLCELLS.2017.0051
p:P4510
wds:Q40160001-3C2C3660-3544-4B6E-975A-20280E6C84E6
wdt:P4510
wd:Q1659584
p:P932
wds:Q40160001-C15AAEED-986E-4890-BC11-DD01AB0592CE
wdt:P932
5523018